Ajay Verma, MD, PhD, Vice President, Translational Neurology, Biogen Inc., assesses the neurodegeneration problem that will accompany the significant increase in the elderly population. He discusses the...
Dr Cohen reviews his presentation from the July 25 AIBD regional meeting on using biosimilars as first-line and switch therapy in patients with inflammatory bowel disease.
Stevin Zorn, PhD, discusses research into exploitation of a single mechanism of action for possible treatment and prevention of Alzheimer disease, and a possible shift of focus towards experimenting with...
In this video, Herman Taylor, Jr, MD, MPH, explains how the findings from the Jackson Heart Study question the specifics of making the right diagnosis at the right time among African Americans.
